News
06-12-2015, 02:24 AM
Ovarian cancer shuts down immune system cells that would otherwise act as a first line of defense against the deadly tumor, Weill Cornell Medical College scientists report today. But a therapy that restores the cells' disease-fighting abilities could provide a powerful new strategy to attack the cancer, which kills more than 14,000 women each year.
More... (http://www.news-medical.net/news/20150612/Weill-Cornell-scientists-reveal-how-XBP1-gene-can-trigger-immune-responses-against-ovarian-tumors.aspx)
More... (http://www.news-medical.net/news/20150612/Weill-Cornell-scientists-reveal-how-XBP1-gene-can-trigger-immune-responses-against-ovarian-tumors.aspx)